跳至主要内容
临床试验/NCT06082505
NCT06082505已完成不适用

A Community Based Program to Increase Breast and Cervical Cancer Screening and HPV Vaccination to Reduce the Impact of Breast and Cervical Cancer Among Latinas.

The University of Texas Health Science Center, Houston2 个研究点 分布在 1 个国家目标入组 8,262 人开始时间: 2016年11月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
8,262
试验地点
2
主要终点
Number of women 40 years and older who complete mammogram screening

研究概览

简要总结

The purpose is to evaluate implementation of a community-based prevention project aimed at increasing early detection and prevention of breast and cervical cancer through education and navigation and to increase breast and cervical cancer screening and Human Papillomavirus (HPV) vaccination in underserved Latinas.

详细描述

This is an evaluation of the Salud en Mis Manos community health worker-delivered breast and cervical cancer screening promotion program. The investigators evaluate the effect of the program on increasing participant breast and cervical cancer screening and HPV vaccination, using a one-group pre-post study design (March 2017 - May 2019). The investigators also describe the implementation of the program during a longer time period (November 2016 - May 2019).

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Screening
盲法
None

入排标准

年龄范围
21 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Self identifies as Hispanic or Latina
  • Lives in Texas
  • Breast cancer screening group: have not had a mammogram in the past 2 years, and are 40 years of age and older
  • Cervical cancer screening group: have not had a Pap test in the past 3 years and are 21 years of age and older
  • HPV vaccination group: are women 21-26 years of age, and have not initiated the HPV vaccine series
  • Age limit for breast cancer screening group: 40 years and older
  • Age limit for cervical cancer screening group (Pap test): 21 years and older
  • Age limit for HPV vaccination group: 21-26 years

排除标准

  • Current pregnancy
  • Current or prior cancer diagnosis

结局指标

主要结局

Number of women 40 years and older who complete mammogram screening

时间窗: Between baseline and end of study (about 9 months)

Among women 40 years and older that have not had a mammogram in the past two years, enrolled in the program and completed baseline and follow-up surveys.

Number of women 21-65 years old who complete Pap test screening

时间窗: Between baseline and end of study (about 9 months)

Among women 21 - 65 years old that have not had a Pap test in the past three years, enrolled in the program and completed baseline and follow-up surveys.

Number of women 21-26 years old who initiate their HPV vaccination series.

时间窗: between baseline and end of study (about 9 months)

Among women 21-26 years old that have not yet initiated their HPV vaccination series, enrolled in the program and completed baseline and follow-up surveys.

次要结局

  • Number of participants who received a clinical breast exam(between baseline and end of study (about 9 months))
  • Number of participants who received the third dose of HPV vaccine(between baseline and end of study (about 9 months))
  • Number of participants who received the second dose of HPV vaccine(between baseline and end of study (about 9 months))

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Lara Savas

Associate Professor

The University of Texas Health Science Center, Houston

研究点 (2)

Loading locations...

相似试验

Salud en Mis Manos - Breast and Cervical Cancer... | 临床试验